akineton
Pharmaranks rates Akineton 3.6/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Akineton (Biperiden Lactate) is a medication used to treat Parkinson Disease, Drug-Related Side Effects and Adverse Reactions.
Biperiden Lactate · by Abbvie
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Biperiden Lactate
- Form
- Injectable, Tablet
- Strength
- Biperiden Lactate 5MG/ML
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- Manufacturer
- Abbvie
- FDA application
- NDA012418
- Availability
- Discontinued (per FDA)
May treat (source: NIH RxClass)
Dosage forms
Injectable and Tablet
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Akineton treat?
- Akineton (Biperiden Lactate) may be used to treat parkinson disease, drug-related side effects and adverse reactions, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How is Akineton rated?
- pharmaranks gives Akineton a composite score of 3.6 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Akineton?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Akineton. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Akineton?
- Akineton is marketed by Abbvie. You can see Abbvie's full profile, rating, and other products on pharmaranks.
- Is Akineton a brand-name or generic drug?
- Akineton is a brand-name product with the active ingredient Biperiden Lactate.
- Is Akineton available over the counter?
- No. Akineton is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Akineton come in?
- Akineton is currently marketed as injectable and tablet, per the FDA's National Drug Code Directory.
- Is Akineton FDA-registered?
- Akineton is on record with the U.S. FDA under application number NDA012418. You can verify this on its official FDA label.
- Has Akineton been recalled by the FDA?
- Akineton has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Akineton safe?
- There's no single safe-or-not verdict. pharmaranks gives Akineton a recall-safety score of 72/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about BIPERIDEN LACTATE
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 42 reports naming BIPERIDEN LACTATE — the active ingredient in Akineton, and the FDA flagged 98% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- neuroleptic malignant syndrome6 reports
- sluggishness4 reports
- arrhythmia3 reports
- blood creatine phosphokinase increased3 reports
- cold sweat3 reports
- depressed level of consciousness3 reports
- dysarthria3 reports
- hypotension3 reports
Read these as a signal, not a rate. A report does not mean BIPERIDEN LACTATE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 25, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
flumazenil
Flumazenil
gocovri
Amantadine Hydrochloride
mirapex er
Pramipexole Dihydrochloride
ongentys
Opicapone
praxbind
Idarucizumab
neupro
Rotigotine
Compare Akineton head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
akineton
72/100